Business Overview
Crystal Crop Protection Limited, established in 1994 and headquartered in New Delhi with its registered office in Ahmedabad, is a crop solutions company with agrochemicals and seeds at the core of its offerings. Its portfolio spans crop protection products (herbicides, fungicides, insecticides and their combinations), natural crop solutions (bio-stimulants, bio-protectants, plant growth regulators, liquid fertilizers and micro nutrients), technical grade active ingredients, and hybrid seeds for field crops, vegetables and flowers, sold under the Crystal and Saffire brands with over 193 product brands. The Company is among the top three players in pearl millet and mustard seeds, with market shares of 20-22% and 6-7% respectively in Fiscal 2026.
The Company manufactures formulations at four units in Sonipat (Haryana), Anand (Gujarat) and Jammu (two units) with an aggregate installed capacity of 75,962.00 MT, and technicals at Dahej (Gujarat) and Nagpur (Maharashtra) with an aggregate capacity of 4,717.00 MT. Its three seed processing units at Hyderabad and Bengaluru have installed capacities of 48,213.79 MT and 1,722.00 MT respectively, and a new plant is proposed at Jhagadia, Gujarat on 125,714.60 sq. mtrs. Domestic sales contributed 95.38% of revenue from operations in Fiscal 2026, with exports primarily to Bangladesh, Nepal, Tanzania, Uganda, Ethiopia, Japan and the USA. The Company has employed 2,117 full time and 705 contractual employees.
IPO Details
| IPO Date | Nov 18 to Nov 20, 2026 |
| Face Value | ₹ 10/- per share |
| Price Band | ₹ 259 to ₹ 272 per share |
| Lot Size | 55 shares and in multiples thereof |
| Issue Size | ₹ 455.49 Crores (at upper price band) |
| Issue Type | Fresh Issue – ₹ 354.77 Crores and Offer for Sale of ₹ 100.71 Crores. |
Objects of the Offer
- Repayment/pre-payment, in full or part, of certain borrowings availed by the Company – ₹ 247.94 Crores.
- Investment in Material Subsidiary, Saffire Crop Science Private Limited, for repayment/pre-payment of its outstanding borrowings – ₹ 22.06 Crores.
- Funding inorganic growth and general corporate purposes.
Key Strengths and Opportunities
-
Strong R&D Capabilities backed by Patents and Registrations:
The Company operates its in-house Key Research Development Centre at Sonipat, Haryana, established in 2016, which is GLP compliant and recognised by the Department of Scientific and Industrial Research. It has applied for 28 patents, of which 18 have been granted in India and 2 overseas, and 14 patents had been commercialised as of March 31, 2026. It holds 139 domestic technical registrations, 601 domestic formulation registrations and 147 export registrations. Its 24 products registered under Section 9(3) of the Insecticides Act supported a gross margin of 53.00% in the Crystal branded formulation business for the three months ended June 30, 2026, while the innovation rate of this business rose to 19.56% in Fiscal 2026 from 16.02% in Fiscal 2024. Investment in seeds R&D grew from ₹ 23.22 Crores in Fiscal 2024 to ₹ 39.54 Crores in Fiscal 2026. -
Pan India Distribution with a Multi-pronged Go-to-market Strategy:
As of June 30, 2026, the Company has a network of 14,717 independent distributors across 23 states and four union territories. Its two brand architecture in crop protection, Crystal and Saffire, is served through dedicated, non-overlapping distribution channels and separate sales teams, with a brands sales team of 729 employees including 132 field marketing managers, and 489 employees in the seeds business. Farmer reach is extended through 1,038 Crystal Doctors and 342 Saffire Doctors, along with 705 field officers for field crop seeds and 158 for vegetable and flower seeds. -
Track Record of Strategic Acquisitions and Brand Scale up:
The Company has integrated brands acquired from multinationals including Bavistin (BASF, 2016), Proclaim, Tilt and Blue Copper (Syngenta, 2018), Furadan (FMC, 2019), Dursban and Nurelle D (Dow) and Gramoxone (Syngenta, 2023), along with the seeds businesses of Bayer (2021) and I&B Seeds (2024). Bavistin revenue grew from ₹ 54.46 Crores post acquisition to ₹ 93.87 Crores in Fiscal 2026, Proclaim, Tilt and Blue Copper from ₹ 138.39 Crores to ₹ 200.60 Crores, and the Syngenta fodder, grain sorghum and pearl millet seeds business from ₹ 20.52 Crores to ₹ 48.69 Crores, demonstrating its ability to scale acquired brands through its distribution network.
Key Risks
-
Ongoing Criminal and Regulatory Proceedings against the Company and Promoters:
The Company, Promoters Nand Kishore Aggarwal and Ankur Aggarwal and certain erstwhile directors face a CBI chargesheet dated December 24, 2021 alleging fraudulent claims of terminal excise duty refunds of ₹ 75.53 Crores, 3.47% of net worth as of June 30, 2026, out of aggregate refunds of ₹ 110.33 Crores claimed through 101 applications filed in Fiscals 2015 and 2016. Pendency of the matter has already held back a no objection certificate for overseas investment, and an adverse outcome could lead to fines, disqualification of Directors, attachment of assets and reputational damage. -
Raw Material Dependence on Imports and Key Suppliers:
Cost of materials consumed formed 68.95% of total expenses in Fiscal 2026, and raw materials sourced from international suppliers rose to 60.63% of total raw material cost in the three months ended June 30, 2026 from 42.28% in Fiscal 2026. The top ten suppliers accounted for 51.33% of raw material purchases in the June 2026 quarter, and apart from a few China based suppliers the Company has no long term or exclusive supply agreements, exposing it to supply disruptions, anti-dumping measures and price volatility that may not be passed on. -
Rising Cost of Supplier Financing Arrangements:
Interest cost on supplier financing arrangements rose from ₹ 1.09 Crores in Fiscal 2024 to ₹ 5.92 Crores in Fiscal 2025 and ₹ 15.61 Crores in Fiscal 2026. Any increase in interest rates, reduction in sanctioned limits or withdrawal of these arrangements would raise financing costs and working capital requirements, affecting profitability and cash flows.
Financial Snapshot
| Period Ended | FY26 | FY25 | FY24 |
| Total Income | 3,180.98 | 2,731.94 | 2,271.71 |
| YoY Growth | 16.4% | 20.3% | – |
| EBITDA | 456.23 | 315.28 | 209.06 |
| YoY Growth | 44.7% | 50.8% | – |
| EBITDA Margin | 14.47% | 11.72% | 9.38% |
| Profit After Tax | 144.91 | 118.39 | 87.24 |
| YoY Growth | 22.4% | 35.7% | – |
| PAT Margin | 4.56% | 4.33% | 3.84% |
| ROE | 7.94% | 8.31% | 6.59% |
| Net Worth | 2,039.76 | 1,600.10 | 1,488.39 |
| Total Borrowings | 820.04 | 947.02 | 577.29 |



